The original version of this article was published with an accidental exclusion of a first author in one of the references in the reference list. We overlooked this error in the following original reference:
Francois, S., Huynh, A., Cassinat, B., Bay, J.O., Cornillon, J., Rolland, V., Charbonnier, A., Michallet, M., Boyer, F., Vigouroux, S., et al. (2013). Ruxolitinib before allogeneic hematopoietic stem cell transplantation (HSCT) in patients with myelofibrosis: A preliminary descriptive report of the JAK ALLO Study, a phase II trial sponsored by goelams-FIM in collaboration with the Sfgmtc. Blood 122, 306.
The correct reference, with the correct first author, is as follows:
Robin, M., Francois, S., Huynh, A., Cassinat, B., Bay, J.O., Cornillon, J., Rolland, V., Charbonnier, A., Michallet, M., Boyer, F., et al. (2013). Ruxolitinib before allogeneic hematopoietic stem cell transplantation (HSCT) in patients with myelofibrosis: A preliminary descriptive report of the JAK ALLO Study, a phase II trial sponsored by goelams-FIM in collaboration with the Sfgmtc. Blood 122, 306.
The reference and accompanying citation have now been updated in the online version of our article. We apologize for the oversight.